Optimization of an amplification protocol for misfolded proteins by using relaxed control
暂无分享,去创建一个
[1] V. Calvez,et al. Self-similarity in a general aggregation–fragmentation problem. Application to fitness analysis , 2010, 1011.5468.
[2] Urszula Ledzewicz,et al. Optimal Bang-Bang Controls for a Two-Compartment Model in Cancer Chemotherapy , 2002 .
[3] A General Inverse Problem for the Growth-Fragmentation Equation , 2011, 1110.4798.
[4] A. Zaslavski. Turnpike properties in the calculus of variations and optimal control , 2005 .
[5] V. Calvez,et al. Prion dynamics with size dependency–strain phenomena , 2010, Journal of biological dynamics.
[6] Xamxinur Abdurahman,et al. Resonance of the epidemic threshold in a periodic environment , 2008, Journal of mathematical biology.
[7] Laurent Pujo-Menjouet,et al. Analysis of a model for the dynamics of prions , 2005 .
[8] Pierre Gabriel. Équations de transport-fragmentation et applications aux maladies à prions , 2011 .
[9] B. Permanne,et al. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.
[10] Prion proliferation with unbounded polymerization rates , 2007 .
[11] Nicolas Bacaër,et al. Growth rate and basic reproduction number for population models with a simple periodic factor. , 2007, Mathematical biosciences.
[12] Enrique Zuazua,et al. The turnpike property in finite-dimensional nonlinear optimal control , 2014, 1402.3263.
[13] Urszula Ledzewicz,et al. ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY , 2002 .
[14] M. Doumic,et al. Estimating the division rate for the growth-fragmentation equation , 2013, Journal of mathematical biology.
[15] H. Schättler,et al. ANALYSIS OF MODELS FOR EVOLVING DRUG RESISTANCE IN CANCER CHEMOTHERAPY , 2006 .
[16] Pierre Gabriel,et al. The shape of the polymerization rate in the prion equation , 2010, Math. Comput. Model..
[17] Cyclic amplification of protein misfolding and aggregation. , 2005, Methods in molecular biology.
[18] M A Nowak,et al. Quantifying the kinetic parameters of prion replication. , 1999, Biophysical chemistry.
[19] Pierre Gabriel. Long-time asymptotics for nonlinear growth-fragmentation equations , 2011, 1102.2871.
[20] Urszula Ledzewicz,et al. OPTIMAL CONTROL FOR A CLASS OF COMPARTMENTAL MODELS IN CANCER CHEMOTHERAPY , 2003 .
[21] Pierre Gabriel,et al. Eigenelements of a General Aggregation-Fragmentation Model , 2009, 0907.5467.
[22] Jean Clairambault,et al. Comparison of Perron and Floquet Eigenvalues in Age Structured Cell Division Cycle Models , 2008, 0812.0803.
[23] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[24] Estimating the Division Rate for the Growth-Fragmentation Equation , 2017 .
[25] Thierry Goudon,et al. Scaling limit of a discrete prion dynamics model , 2009, 0907.2297.
[26] Urszula Ledzewicz,et al. Drug resistance in cancer chemotherapy as an optimal control problem , 2005 .
[27] J. Griffith,et al. Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.
[28] Laurent Pujo-Menjouet,et al. A mathematical analysis of the dynamics of prion proliferation. , 2006, Journal of theoretical biology.
[29] B. Perthame. Transport Equations in Biology , 2006 .
[30] Optimal growth for linear processes with affine control , 2012, 1203.5189.
[31] E B Lee,et al. Foundations of optimal control theory , 1967 .
[32] Christoph Walker,et al. On the solvability of a mathematical model for prion proliferation , 2006 .
[33] D. Serre. Matrices: Theory and Applications , 2002 .
[34] P. Michel,et al. Optimal Proliferation Rate in a Cell Division Model , 2006 .
[35] P. Laurençot,et al. Well-posedness for a model of prion proliferation dynamics , 2007 .
[36] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[37] J. Castilla,et al. In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.
[38] Dietmar Oelz,et al. Size distribution dependence of prion aggregates infectivity. , 2009, Mathematical biosciences.